Search Results - "ROSS, Graham"

Making sense of algorithms: Relational perception of contact tracing and risk assessment during COVID-19 by Liu, Chuncheng, Graham, Ross

“…Governments and citizens of nearly every nation have been compelled to respond to COVID-19. Many measures have been adopted, including contact tracing and risk…”
Get full text

Using analytical performance specifications in a medical laboratory by Jones, Graham Ross Dallas

“…Analytical performance specifications (APS) are used for the quantitative assessment of assay analytical performance, with the aim of providing information…”
Get more information

Revisiting fine-tuning in the MSSM by Ross, Graham G., Schmidt-Hoberg, Kai, Staub, Florian

“…A bstract We evaluate the amount of fine-tuning in constrained versions of the minimal supersymmetric standard model (MSSM), with different boundary conditions…”
Get full text

A unified model of quarks and leptons with a universal texture zero by de Medeiros Varzielas, Ivo, Ross, Graham G., Talbert, Jim

“…A bstract We show that a universal texture zero in the (1,1) position of all fermionic mass matrices, including heavy right-handed Majorana neutrinos driving a…”
Get full text

On the MSSM Higgsino mass and fine tuning by Ross, Graham G., Schmidt-Hoberg, Kai, Staub, Florian

“…It is often argued that low fine tuning in the MSSM necessarily requires a rather light Higgsino. In this note we show that this need not be the case when a…”
Get full text

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy by BASELGA, José, GELMON, Karen A, FUMOLEAU, Pierre, GIANNI, Luca, VERMA, Shailendra, WARDLEY, Andrew, CONTE, Pierfranco, MILES, David, BIANCHI, Giulia, CORTES, Javier, MCNALLY, Virginia A, ROSS, Graham A

“…PURPOSE; Pertuzumab, a human epidermal growth factor receptor 2 (HER2) -targeted monoclonal antibody, potently inhibits HER2 dimerization and HER-mediated…”
Get full text

5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial by Gianni, Luca, Prof, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Starosławska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia Valeria, MD, Magazzù, Domenico, PhD, McNally, Virginia, PhD, Douthwaite, Hannah, MSc, Ross, Graham, FFPM, Valagussa, Pinuccia, BS

“…Summary Background In the primary analysis of the NeoSphere trial, patients given neoadjuvant pertuzumab, trastuzumab, and docetaxel showed a significantly…”
Get full text

Unification and fermion mass structure by Ross, Graham G., Serna, Mario

“…Grand Unified Theories predict relationships between the GUT-scale quark and lepton masses. Using new data in the context of the MSSM, we update the values and…”
Get full text

The generalised NMSSM at one loop: fine tuning and phenomenology by Ross, Graham G., Schmidt-Hoberg, Kai, Staub, Florian

“…We determine the degree of fine tuning needed in a generalised version of the NMSSM that follows from an underlying or R symmetry. We find that it is…”
Get full text

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study by Swain, Sandra M, Dr, Kim, Sung-Bae, MD, Cortés, Javier, MD, Ro, Jungsil, MD, Semiglazov, Vladimir, MD, Campone, Mario, MD, Ciruelos, Eva, MD, Ferrero, Jean-Marc, MD, Schneeweiss, Andreas, MD, Knott, Adam, PhD, Clark, Emma, MSc, Ross, Graham, FFPM, Benyunes, Mark C, MD, Baselga, José, MD

“…Summary Background CLEOPATRA is a phase 3 study to compare the efficacy and safety of pertuzumab, trastuzumab, and docetaxel with placebo, trastuzumab, and…”
Get full text

Discrete R symmetries for the MSSM and its singlet extensions by Lee, Hyun Min, Raby, Stuart, Ratz, Michael, Ross, Graham G., Schieren, Roland, Schmidt-Hoberg, Kai, Vaudrevange, Patrick K.S.

“…We determine the anomaly free discrete R symmetries, consistent with the MSSM, that commute with SU ( 5 ) and suppress the μ parameter and nucleon decay. We…”
Get full text

Non-universal gaugino masses and fine tuning implications for SUSY searches in the MSSM and the GNMSSM by Kaminska, Anna, Ross, Graham G., Schmidt-Hoberg, Kai

“…A bstract For the case of the MSSM and the most general form of the NMSSM (GN-MSSM) we determine the reduction in the fine tuning that follows from allowing…”
Get full text

Analytical performance specifications for EQA schemes - need for harmonisation by Dallas Jones, Graham Ross

“…External Quality Assurance (EQA) is a vital tool in laboratory medicine to assess individual laboratory analytical performance and also the differences between…”
Get more information

A new approach to gauge coupling unification and proton decay by Pokorski, Stefan, Rolbiecki, Krzysztof, Ross, Graham G., Sakurai, Kazuki

“…A bstract An analytical formalism, including RG running at two loop order, is used to link the supersymmetric and GUT spectra in any GUT model in which the…”
Get full text

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial by Gianni, Luca, Dr, Pienkowski, Tadeusz, Prof, Im, Young-Hyuck, Prof, Roman, Laslo, MD, Tseng, Ling-Ming, MD, Liu, Mei-Ching, MD, Lluch, Ana, MD, Staroslawska, Elżbieta, Prof, de la Haba-Rodriguez, Juan, MD, Im, Seock-Ah, Prof, Pedrini, Jose Luiz, MD, Poirier, Brigitte, MD, Morandi, Paolo, MD, Semiglazov, Vladimir, Prof, Srimuninnimit, Vichien, Prof, Bianchi, Giulia, MD, Szado, Tania, PhD, Ratnayake, Jayantha, BSc, Ross, Graham, MD, Valagussa, Pinuccia, BS

“…Summary Background Studies with pertuzumab, a novel anti-HER2 antibody, show improved efficacy when combined with the established HER2-directed antibody…”
Get full text

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer by CORTES, Javier, FUMOLEAU, Pierre, SALVAGNI, Stefania, SERVENT, Veronique, GIANNI, Luca, SCALTRITI, Maurizio, ROSS, Graham A, DIXON, Joanna, SZADO, Tania, BASELGA, José, VALERIA BIANCHI, Giulia, PETRELLA, Teresa M, GELMON, Karen, PIVOT, Xavier, VERMA, Shailendra, ALBANELL, Joan, CONTE, Pierfranco, LLUCH, Ana

“…The combination of pertuzumab and trastuzumab resulted in a clinical benefit rate (CBR) of 50% in patients with human epidermal growth factor receptor 2 (HER2)…”
Get full text

Measurement uncertainty for clinical laboratories - a revision of the concept by Dallas Jones, Graham Ross

“…The uncertainty of a measurement result is a fundamental concept in metrology indicating the range within the "true" value of a measurement should lie…”
Get more information

Estimating Reference Change Values Using Routine Patient Data: A Novel Pathology Database Approach by Røys, Eirik Åsen, Viste, Kristin, Kellmann, Ralf, Guldhaug, Nora Alicia, Alaour, Bashir, Sylte, Marit Sverresdotter, Torsvik, Janniche, Strand, Heidi, Marber, Michael, Omland, Torbjørn, Theodorsson, Elvar, Jones, Graham Ross Dallas, Aakre, Kristin Moberg

“…Abstract Background The reference change value (RCV) is calculated by combining the within-subject biological variation (CVI) and local analytical variation…”
Get full text

Rebuilding public health on more than thoughts and prayers by Graham, J. Ross, Sibbald, Shannon L.

“…Sweeping reviews will be conducted once the COVID-19 pandemic concludes to support public health system strengthening. Unfortunately, these reviews will find…”
Get full text

Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance by Dorji, Dorji, Mooi, Frits, Yantorno, Osvaldo, Deora, Rajendar, Graham, Ross M., Mukkur, Trilochan K.

“…Despite high vaccine coverage, whooping cough caused by Bordetella pertussis remains one of the most common vaccine-preventable diseases worldwide…”
Get full text